Glaukos, based in San Clemente, California, won FDA approval to introduce its iStent inject Trabecular Micro-Bypass System in the United States. The device, designed to treat mild to moderate primary open-angle glaucoma, is implanted alongside cataract surgeries to reduce intraocular pressure.
The implant is tiny, measuring only 0.23 mm x 0.36 mm (Read more...)